Between conscious choices and transformative policies, Zurich is writing a new chapter in the history of cannabis in Europe. And it is inviting more than 900 people to be part of this narrative. 

The Swiss city, known for its precision, organization, and quality of life, is at the forefront of the debate on the conscious and legal use of cannabis, this time betting on a bold expansion of the pilot project “Züri Can – Cannabis with Responsibility.”

Launched in 2023 with the participation of about 2,100 people, the study now opens its doors to more volunteers, aiming to observe, with scientific rigor, the impacts of regulated cannabis consumption on physical and mental health, as well as on the social behaviors of users. An initiative that does not romanticize the substance, but also does not turn a blind eye to its reality; on the contrary, it chooses to understand it.

“We do not want to promote use, but to understand it in a safe environment,” emphasize the study organizers, who unite efforts from the Zurich City Council, the Swiss Federal Institute of Technology (ETH), and the University of Zurich. It is science leading the dialogue with data, empathy, and social responsibility.

Cannabis with Traceability, Control, and Support

Participants of Züri Can can acquire cannabis products at more than 20 licensed points – from pharmacies to social clubs. All items are tested and controlled for quality and origin. The experience is distinguished by creating an environment where consumption is not marginalized, but rather understood through information, medical monitoring, and public health care.

The project also requires commitment: in addition to residing in Zurich and being over 18 years old, it is necessary to be a current cannabis user, undergo an interview, answer questionnaires, and perform periodic medical exams. An honest exchange, where the participant gains legal access to the plant and, in return, collaborates with a study that could influence health policies throughout Europe.

A New Possible Path

Since Switzerland amended its Narcotics Act in 2021, allowing scientific tests with cannabis in controlled environments, other cities have also embraced the idea. Basel, Bern, Geneva, and Lausanne are already developing similar studies. Zurich's proposal, however, gained notoriety for its comprehensive and transparent model – and is watched closely by other European countries, such as Germany and the Netherlands, which are also seeking alternatives to prohibitionism.

With information from DolceVita.